US Stock MarketDetailed Quotes

STRO Sutro Biopharma

Watchlist
  • 3.720
  • -0.045-1.20%
Trading Jul 22 10:11 ET
304.27MMarket Cap-1978P/E (TTM)

Sutro Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
0.17%28.1M
Operating revenue
2.64%13.01M
126.84%153.73M
1,217.44%113.72M
-32.70%16.92M
-62.94%10.41M
114.92%12.67M
9.52%67.77M
-18.98%8.63M
195.26%25.15M
0.17%28.1M
Cost of revenue
Gross profit
Operating expense
26.75%69.6M
23.53%243.01M
21.98%70.57M
31.45%60.94M
19.20%56.59M
21.95%54.91M
22.64%196.72M
26.62%57.85M
7.33%46.36M
25.42%47.48M
Selling and administrative expenses
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
20.71%15.14M
-General and administrative expense
-17.99%12.72M
5.11%62.58M
14.17%16.8M
4.28%15.27M
-0.95%15M
3.15%15.51M
6.32%59.54M
-6.62%14.72M
-11.73%14.64M
20.71%15.14M
Research and development costs
44.36%56.88M
31.53%180.43M
24.64%53.77M
44.00%45.67M
28.64%41.59M
31.37%39.4M
31.39%137.17M
44.13%43.14M
19.22%31.71M
27.75%32.33M
Operating profit
-33.98%-56.59M
30.76%-89.28M
187.67%43.15M
-107.52%-44.01M
-138.29%-46.18M
-7.93%-42.24M
-30.87%-128.94M
-40.49%-49.22M
38.83%-21.21M
-97.64%-19.38M
Net non-operating interest income expense
-1,144.37%-5.3M
-8,577.06%-9.24M
-247.96%-4.17M
-132.53%-4.13M
-29.72%-515K
21.26%-426K
104.26%109K
646.71%2.82M
-149.51%-1.77M
40.92%-397K
Non-operating interest income
60.00%4.1M
319.97%14.51M
114.19%4.56M
348.72%4.55M
1,342.64%2.84M
2,106.90%2.56M
498.79%3.46M
2,116.67%2.13M
830.28%1.01M
12.57%197K
Non-operating interest expense
214.70%9.4M
609.80%23.75M
1,360.03%8.73M
211.15%8.68M
465.15%3.36M
354.49%2.99M
6.66%3.35M
-213.24%-693K
240.00%2.79M
-29.87%594K
Other net income (expense)
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
-186.38%-3.74M
Gain on sale of security
152.62%3.68M
-18.24%9.92M
-33.14%7.89M
-80.15%694K
322.72%8.32M
-1,341.92%-6.99M
372.34%12.13M
558.88%11.81M
-22.02%3.5M
-186.38%-3.74M
Income before tax
-17.23%-58.21M
24.08%-88.6M
235.49%46.87M
-143.46%-47.45M
-63.21%-38.37M
-26.96%-49.66M
-10.58%-116.7M
9.26%-34.59M
36.94%-19.49M
-282.18%-23.51M
Income tax
0
627.68%18.19M
15.81M
1.84M
-93.96%151K
395K
2.5M
0
0
2.5M
Net income
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
Net income continuous Operations
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
Minority interest income
Net income attributable to the parent company
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-16.31%-58.21M
10.41%-106.79M
189.80%31.07M
-152.89%-49.28M
-48.10%-38.52M
-27.97%-50.05M
-12.95%-119.2M
9.26%-34.59M
36.94%-19.49M
-322.82%-26.01M
Basic earnings per share
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
-323.08%-0.55
Diluted earnings per share
-11.76%-0.95
24.26%-1.78
185.25%0.52
-118.92%-0.81
-16.36%-0.64
-1.19%-0.85
-2.62%-2.35
26.51%-0.61
44.78%-0.37
-323.08%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M0.17%28.1M
Operating revenue 2.64%13.01M126.84%153.73M1,217.44%113.72M-32.70%16.92M-62.94%10.41M114.92%12.67M9.52%67.77M-18.98%8.63M195.26%25.15M0.17%28.1M
Cost of revenue
Gross profit
Operating expense 26.75%69.6M23.53%243.01M21.98%70.57M31.45%60.94M19.20%56.59M21.95%54.91M22.64%196.72M26.62%57.85M7.33%46.36M25.42%47.48M
Selling and administrative expenses -17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M20.71%15.14M
-General and administrative expense -17.99%12.72M5.11%62.58M14.17%16.8M4.28%15.27M-0.95%15M3.15%15.51M6.32%59.54M-6.62%14.72M-11.73%14.64M20.71%15.14M
Research and development costs 44.36%56.88M31.53%180.43M24.64%53.77M44.00%45.67M28.64%41.59M31.37%39.4M31.39%137.17M44.13%43.14M19.22%31.71M27.75%32.33M
Operating profit -33.98%-56.59M30.76%-89.28M187.67%43.15M-107.52%-44.01M-138.29%-46.18M-7.93%-42.24M-30.87%-128.94M-40.49%-49.22M38.83%-21.21M-97.64%-19.38M
Net non-operating interest income expense -1,144.37%-5.3M-8,577.06%-9.24M-247.96%-4.17M-132.53%-4.13M-29.72%-515K21.26%-426K104.26%109K646.71%2.82M-149.51%-1.77M40.92%-397K
Non-operating interest income 60.00%4.1M319.97%14.51M114.19%4.56M348.72%4.55M1,342.64%2.84M2,106.90%2.56M498.79%3.46M2,116.67%2.13M830.28%1.01M12.57%197K
Non-operating interest expense 214.70%9.4M609.80%23.75M1,360.03%8.73M211.15%8.68M465.15%3.36M354.49%2.99M6.66%3.35M-213.24%-693K240.00%2.79M-29.87%594K
Other net income (expense) 152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M-186.38%-3.74M
Gain on sale of security 152.62%3.68M-18.24%9.92M-33.14%7.89M-80.15%694K322.72%8.32M-1,341.92%-6.99M372.34%12.13M558.88%11.81M-22.02%3.5M-186.38%-3.74M
Income before tax -17.23%-58.21M24.08%-88.6M235.49%46.87M-143.46%-47.45M-63.21%-38.37M-26.96%-49.66M-10.58%-116.7M9.26%-34.59M36.94%-19.49M-282.18%-23.51M
Income tax 0627.68%18.19M15.81M1.84M-93.96%151K395K2.5M002.5M
Net income -16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M
Net income continuous Operations -16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M
Minority interest income
Net income attributable to the parent company -16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -16.31%-58.21M10.41%-106.79M189.80%31.07M-152.89%-49.28M-48.10%-38.52M-27.97%-50.05M-12.95%-119.2M9.26%-34.59M36.94%-19.49M-322.82%-26.01M
Basic earnings per share -11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37-323.08%-0.55
Diluted earnings per share -11.76%-0.9524.26%-1.78185.25%0.52-118.92%-0.81-16.36%-0.64-1.19%-0.85-2.62%-2.3526.51%-0.6144.78%-0.37-323.08%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg